# CIPROFLOXACIN AND DEXAMETHASONE
> **ANDA215768** · Abbreviated New Drug Application (Generic) · Sponsor: SENTISS · Approved 2023-06-09
## Drug
- **FDA Application Number:** ANDA215768
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CIPROFLOXACIN AND DEXAMETHASONE
- **Generic name:** CIPROFLOXACIN AND DEXAMETHASONE
- **Active ingredients:** CIPROFLOXACIN; DEXAMETHASONE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OTIC
- **Marketing status:** Prescription
- **Sponsor:** SENTISS
- **Manufacturer:** ARMAS PHARMACEUTICALS INC.
- **First approval:** 2023-06-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215768)
---
*AI Analytics · CC0 1.0*